January 13 - 17, 2014
Renaissance Hotel and Palm Springs Convention Center Palm Springs, California

A Community Dedicated to the
Evolving Field and Future of Biotherapeutics

2014 Speakers

Margaret Ackerman, Ph.D., Assistant Professor, Engineering, Dartmouth University
 

Greg Adams, Ph.D., Co-Leader, Developmental Therapeutics Program, Fox Chase Cancer Center

Alina A. Alexeenko, Ph.D., Assistant Professor, School of Aeronautics and Astronautics, 
Purdue University

Richard Altman, MS, Research Scientist, Alexion Pharmaceuticals

Steven P. Allen, Ph.D., Manager, Biologics Process Design R&D, Diagnostics R&D, Abbott
 

Mark Arbing, Ph.D., Director, Protein Expression Technology Center, UCLA-DOE Institute for Genomics & Proteomics

Pooja Arora, Ph.D., Senior Manufacturing Technical Specialist,
 Genentech, Inc.

Igor Astsaturov, M.D., Ph.D., Assistant Professor, Fox Chase Cancer Center 

Shujun Bai, Ph.D., Scientist, Protein Pharmaceutical Sciences, Biogen Idec 

Ronald Bates, Ph.D., Director, Downstream Processing and Stability, Allergan, Inc. 

William P. Beierschmitt, Ph.D., DABT, FATS, Regulatory Strategy Lead, Worldwide Research and Development Drug Safety Research & Development, Pfizer, Inc.  

Lisa M. Bergeron, Ph.D., Principal Scientist, Biotherapeutics Discovery & Engineering, Zoetis Inc. 

Lawrence Berliner, Professor of Chemistry and Biochemistry, Chemistry and Biochemistry, University of Denver; Emeritus, Ohio State University 

Bakul Bhatnagar, Ph.D., Principal Scientist, Formulation & Process Development, Pfizer, Inc. 

Murali Bilikallahalli, Ph.D., Associate Director, Formulation Sciences, Proteins, Vaccines & Oligos, MedImmune 

Marco Blanco, Ph.D., Postdoctoral Researcher, Chemical and Biomolecular Engineering, University of Delaware 

Georg Blaser, Ph.D. Group Leader, Applied Protein Services, Lonza Biologics 

Greg Bleck, Ph.D., R&D Platform Director, Biologics, Catalent Pharma Solutions 

Robin Bogner, Ph.D., Associate Professor, School of Pharmacy, University of Connecticut

Sarah Bondos, Ph.D., Assistant Professor, Molecular & Cellular Medicine, Texas A&M University
 

James Brady, Ph.D., Director, Technical Applications, MaxCyte, Inc. 

Brooks Boyd, Ph.D., Senior Director, Pharmaceutical Development, Zogenix, Inc. 

Mark Brader, Ph.D., Principal Scientist, Biogen Idec

David Bramhill, Ph.D., Founder, Bramhill Biological Consulting, LLC
 

Jeffrey Breit, Ph.D., Director, Pharmaceutical, Bend Research 

Randall Brezski, Ph.D., Senior Scientist, Janssen R&D 

Stephen T. Brown, Ph.D., Chief Technical Officer, Valneva 

Ellen Brune, Ph.D., CSO, Boston Mountain Biotech 

Peter Brünker, Ph.D., Head, Large Molecule Research, Pharma Research and Early Development (pRED), Roche Glycart AG 

Christopher Brynczka, Ph.D., Senior Toxicologist, Toxicology, Gradient Corp. 

David Buckler, Ph.D., Director, Therapeutic Proteins, Regeneron Pharmaceuticals 

Russell G. Burge, Ph.D., Application Scientist, Freeslate, Inc. 

 Diane J. Burgess, Ph.D., Board of Trustees Distinguished Professor of Pharmaceutics, Department of Pharmaceutical Sciences, University of Connecticut 

Gareth Butland, Ph.D., Staff Scientist, Lawrence Berkeley National Laboratory 

Katharine Cain, Ph.D., Principal Scientist, Protein Expression and Purification Group, UCB 

Julio A. Camarero, Ph.D., Associate Professor, Pharmacology and Pharmaceutical Sciences, University of Southern California 

Wenjin Cao, Ph.D., Senior Scientist, Amgen, Inc. 

Susan Callahan, Ph.D., Senior Associate Scientist, Amgen 

Jason Cameron, Science Manager, Bioprocess Characterisation, Novozymes Biopharma UK Ltd 

Allan Capili, Ph.D., Scientist, Protein Biochemistry, Biogen Idec 

Steven Chamow, Ph.D., Principal Consultant, Chamow & Associates, Inc.

Jean-Francois Chaubard, MSc., Director, New Product Development, GSK Vaccines
 

David Cipolla, Ph.D., Senior Director, Pharmaceutical Sciences, Aradigm Corp 

Jason K. Cheung, Ph.D., Principal Scientist, Sterile Product Development, Merck

Henry C. Chiou, Ph.D., Senior Product Manager, Life Technologies
 

Partha Chowdhury, Ph.D., Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune, Inc. 

Leslie Cianella, EMBA, CPIM, CQA, Senior Sourcing and Procurement Manager, MedImmune, Inc. 

Jennifer Cochran, Ph.D., Associate Professor, Bioengineering & Chemical Engineering, Stanford University 

Russell Coleman, Senior Scientist, Pfēnex Inc.   

Caroline Colley, Ph.D., Senior Scientist, Antibody Discovery and Protein Engineering, MedImmune

Christopher R. Corbeil, Ph.D., Chemical Computing Group
 

Peter Cramer, AIA ,Vice President, M+W U.S., Inc., - A Company of the M+W Group 

Sean Cullen, Development Scientist, Technical Development, Genzyme Ireland Ltd in collaboration with University College Cork 

Tony D'Amore, Ph.D., MBA, Associate Vice President, Bioprocess R&D North America, Sanofi Pasteur 

Juan Davagnino, Ph.D., Senior Director, KBI Biopharma 

Weiguo Dai, Ph.D., Scientific Director, Janssen Fellow, Drug Product Development, Janssen Research & Development 

Yamuna Dasarathy, Ph.D., MBA, Director, Marketing, Pall Life Sciences 

Camille Delebecque, Ph.D., Founder and CEO, SynBio Consulting 

Guy de Roo, Ph.D., Project Leader, Downstream Processing, Biopharmaceuticals, Synthon  

Kristin DeFife, Ph.D., Director, Biologics, Ajinomoto Althea

Dominick DeGrazio, Associate Scientist, Analytical Laboratory, West Pharmaceutical Sciences
 

Alexei Degterev, Ph.D., Associate Professor, Biochemistry, Tufts University 

John Desjarlais, Ph.D., Vice President, Research, Xencor 

Dimiter S. Dimitrov, Ph.D., Senior Investigator, Protein Interactions Group, National Cancer Institute, NIH 

Robert F. Dream, PE, Principal, HDR Company LLC. 

André Dumetz, Ph.D., Investigator, GlaxoSmithKline 

Aris N. Economides, Ph.D., Senior Director, Genome Engineering Technologies Group & Skeletal Diseases TFA Group, Regeneron Pharmaceuticals, Inc. 

Markus Engel, Associate Director, Upstream Manufacturing, Biopharma Operations, Boehinger-Ingelheim GmbH & Co., KG 

Joachim Feldwisch, Ph.D., Director, Preclinical Development, Affibody AB 

Igor Fisch, Ph.D., CEO, Selexis SA 

Mick Foley, Ph.D., CSO, Biochemistry, AdAlta 

Andrew Fosberry, Ph.D., Manager, Expression & Fermentation Sciences, Biological Reagents and Assay Development, PTS, GlaxoSmithKline Research & Development Limited 

Germaine Fuh, Ph.D., Senior Scientist, Antibody Engineering, Genentech, Inc. 

David W. Galbraith, Ph.D., Professor, Plant Sciences & Bio5 Institute, University of Arizona 

Brian Gerwe, Ph.D., Product Manager,  PerkinElmer 

Ronald Gillespie, Ph.D., Scientist, Purification Process Development, Amgen, Inc. 

William Gillette, Ph.D., Senior Scientist, SAIC-Frederick, Inc. 

John Godshalk, Senior Consultant, GMP, CMC, Biologics Consulting Group, Inc. and former Review/Inspector, Division of Manufacturing and Product Quality, CBER, U.S. FDA 

Adam Goldstein, Principal Engineer, Genentech, Inc.

Bing Gong, Ph.D., Senior Research Biologist, Glycofi/Merck
 

Kenneth D. Green, Ph.D., Director, Continuous Improvement, Global Technical Services, Pfizer, Inc. 

Michael Gross, Ph.D., Owner and Principal Consultant, Chimera Consulting North America 

Maria Groves, Ph.D., Senior Scientist, Lead Generation, MedImmune 

Jijie Gu, Ph.D., Senior Principal Research Scientist, Global Biologics, AbbVie Pharmaceuticals 

Jianxin Guo, Ph.D., Principal Scientist, Pharmaceutical Sciences, Pfizer 

Amy M. Heinz, Ph.D., Senior Research Scientist, Battelle 

Brandan Hillerich, Ph.D., Managing Director, High Throughput Protein Production, Albert Einstein College of Medicine 

Barry Holwerda, Ph.D., President, Molecular Throughput, Inc. 

Michael D. Hooven, President and CEO, Enable Injections, LLC 

Ivan Horak, M.D., CSO & CMO, Symphogen 

Robert Horlick, Ph.D., Senior Director, Molecular Biology, AnaptysBio, Inc. 

Arnie Horwitz, Ph.D., Senior Director, Expression Technologies, XOMA 

Chung-Ming Hsieh, Ph.D., Associate Director, AbbVie Bioresearch Center 

Jeffrey W. Hudgens, Ph.D., Research Chemist, Institute for Bioscience and Biotechnology Research, BioProcess Measurements Group, Biomolecular Measurement Division, NIST 

Terry Hudson, Ph.D., Associate Director, Process Development Engineering, Genentech, Inc. 

Huw Hughes, Ph.D., Senior Director, Laboratory Sciences, Zoetis, Inc. 

Desmond G. Hunt, Ph.D., Senior Scientific Liaison, Department of Standards Development, United States Pharmacopoeia 

Ian Hunt, Ph.D., Group Leader, Protein Sciences, Novartis 

John Iannone, Program Manager and Technical Specialist, Toxikon Corporation 

Tomoyuki Igawa, Ph.D., Group Manager, Research Division, Chugai Pharmaceutical Co., Ltd.

Tetsuya Ishino, Ph.D., Senior Principal Scientist, Pfizer
 

Edmond W. Israelski, Ph.D., Director, Human Factors, Combination Product Development, AbbVie 

David Y. Jackson, Ph.D., Principal Scientist, ADC Discovery, Igenica, Inc. 

Dennis Jenke, Ph.D., Baxter Distinguished Scientist, Technology Resources, Baxter Healthcare Corp. 

Hua Jiang, Ph.D., Director, Downstream Purification, Novavax, Inc. 

Krista Johnson, MSc, Research Scientist, Alexion Pharmaceuticals 

Mike Johnson, Life Science Applications Engineer, Entegris 

R. Mark Jones, Ph.D., Senior Scientist, Fraunhofer USA Center for Molecular Biotechnology 

Robert S. Kahn, M.D., CPI, Senior Safety Scientist, Early Clinical Development, Global Safety Risk Management, Genentech, Inc.

Devendra (Davy) S. Kalonia, Ph.D., Professor of Pharmaceutics, Department of Pharmaceutical Sciences, University of Connecticut
 

Vishal Kamat, Ph.D., Scientist, Biomolecular HTS Center, Therapeutic Proteins, Regeneron Pharmaceuticals 

Pankaj Karande, Ph.D., Assistant Professor, Department of Chemical & Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute

Gunnar Kaufmann, Ph.D., Senior Director, R&D,
 Sorrento Therapeutics, Inc. 

Timothy Kelly, Ph.D., Vice President, Biopharmaceutical Development, KBI Biopharma, Inc. 

H. Steven Kennedy, Director, Life Sciences + Chemicals 

Jong-Mook Kim, Ph.D., Director, Cell Science Team, R&D Division, Celltrion Inc. 

Kyu-Tae Kim, Ph.D., Director, Therapeutic Antibodies, AbClon Inc. 

Csaba Kiss, Ph.D., Team Leader, Bioscience Division, Los Alamos National Laboratory 

Joseph Kittle, Jr., Ph.D., Assistant Professor, Chemistry and Biochemistry, Ohio University and CSO, Molecular Technologies Laboratories, LLC 

John Knighton, MBA, Senior Director, API Large Molecule Technologies & Alliances, Janssen R&D 

Curtis Knox, Vice President, Marketing & Sales, Lucigen Corp. 

Vinodh Kurella, Ph.D., Research Fellow, Bioinformatics, Harvard Medical School 

Jean E. Lachowicz, Ph.D., CSO, Angiochem 

Philippe Lam, Ph.D., Senior Engineer, Pharmaceutical Processing & Technology Development, Genentech, Inc. 

John M. Lambert, CSO & Executive Vice President, ImmunoGen, Inc 

Jim Larrick, Ph.D., CEO, Panorama Research 

Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire 

Olivier Laurent, Ph.D., Vice President, CMC, Ambrx, Inc. 

Brian Lee, Ph.D., President, PBS Biotech 

Wibke Lembke, Ph.D., Scientist, Covagen AG  

Andrea Leone-Bay, Ph.D., Vice President, Pharmaceutical R&D, MannKind Corp. 

Howard L. Levine, Ph.D., President, BioProcess Technology Consultants 

Hong Liu, Ph.D., Senior Research Associate, Early Stage Pharmaceutical Development, Genentech 

Silvia Locatelli-Hoops, Ph.D., Scientist, Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH)  

Thorsten Lorenz, Ph.D., Principal Scientist, Integrated Biologics Profiling, Novartis Pharma AG 

Dale Ludwig, Ph.D., Vice President, Research, Biologics Technology, ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company 

Junfen Ma, Ph.D., Principal Scientist, Amgen 

John L. Marquardt, Jr., J.D., M.B.A., Ph.D., Attorney at Law, Marquardt Law 

Jerold Martin, MSc, Chairman, BPSA BoD and Technology (E+L) Committee 

Thi-Sau Migone, Ph.D., CSO, Igenica 

Samir Mitragotri, Ph.D., Professor, Chemical Engineering, Founding Director, Center for Bioengineering, University of California, Santa Barbara 

Nicolas Moniotte, Ph.D., Technology Development Leader, R&D Formulation Development, GlaxoSmithKline Vaccines 

Jamie Moore, Ph.D., Director, Genentech, Inc. 

Vamsi Mudhivarthi, Ph.D., Postdoctoral Fellow, Pharmaceutical Sciences, University of Connecticut 

Thomas Müller-Späth, Ph.D., CSO, ChromaCon AG 

Jennifer Nemeth, Ph.D., Associate Scientific Director, Biologics Discovery Program Leader, Janssen R&D LLC 

Kumudini Nicholas, MSc, Advisor/Team Leader, Pharmaceutical Quality Review, Generic Drugs Quality, Bureau of Pharmaceutical Sciences, Therapeutic Products Directorate, Health Canada (invited) 

Sesha Neervannan, Ph.D., Vice President, Pharmaceutical Development, Allergan, Inc. 

David F. Nicoli, Ph.D., Vice President, R&D, Particle Sizing Systems, LLC 

Andrew E. Nixon, Ph.D., Vice President, Discovery Research, Dyax
 

Gunnar Kaufmann, Ph.D., Senior Director, R&D, Sorrento Therapeutics, Inc 

Venkat R. Koganti, Ph.D., MBA, Associate Director, Formulation & Process Development, Celsion Corp. 

John de Kruif, Ph.D., CSO, Merus Biopharmaceuticals

Vinodh Kurella, Ph.D., Visiting Research Fellow, C3 Bioinformatics, Harvard Medical School
 

Steven LaBrenz, Ph.D., Scientific Director, Drug Product Development, Janssen R&D 

William J. Lambert, Ph.D., Fellow, Drug Delivery and Device Development, MedImmune, Inc. 

Brian Lee, Ph.D., President, PBS Biotech 

Abraham M. Lenhoff, Ph.D., Chair & AP Colburn Professor, Chemical & Biomolecular Engineering Delaware Biotechnology Institute, University of Delaware 

Hanns-Christian Mahler, Ph.D., Head Pharmaceutical Development & Supplies, Biologics EU, F. Hoffmann-La Roche 

Prakash Manikwar, Ph.D., Scientist I, Formulation Sciences, MedImmune, Inc. 

Dr.-Ing. Kathleen Mihlbachler, Independent Consultant 

Sherie Morrison, Ph.D., Professor, Microbiology Immunology & Molecular Genetics, University of California, Los Angeles 

Steven L. Nail, Ph.D., Senior Baxter Research Scientist, Pharmaceutical Research & Development, Baxter Healthcare Corp. 

Yasser Nashed-Samuel, Ph.D., Principal Scientist, Process and Product Development, Amgen, Inc. 

Vishal C. Nashine, Ph.D., Senior Research Investigator, Drug Product Science & Technology, Bristol-Myers Squibb Co. 

David Nannemann, Ph.D., Postdoctoral Scholar, Chemistry and Pharmacology, Vanderbilt University 

Ulrik Nielsen, Ph.D., CSO, Merrimack Pharmaceuticals 

Wolfgang Noe, Ph.D., Vice President, Technical Operations, Agensys Inc.

Seamus O’Connor, Ph.D., Senior Analytical Scientist, Analytical Sciences, Industrial Operations and Product Supply, Regeneron Pharmaceuticals, Inc.
 

Satoshi Ohtake, Ph.D., Senior Principal Scientist, Pharmaceutical R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc. 

Angelica Olcott, Ph.D., MFI Product Manager, ProteinSimple 

Takeshi Omasa, Ph.D., Professor, Institute of Technology and Science, University of Tokushima 

Ray Owens, Ph.D., NDM Senior Research Fellow, Division of Structural Biology, Oxford Protein Production Facility, University of Oxford 

Sadettin S. Ozturk, Ph.D., Head, Process and Analytical Development, MassBiologics 

Michele Pallaoro, Ph.D., Unit Head, Formulation Analytics, Novartis Vaccines & Diagnostics 

Michael Pikal, Ph.D., Pfizer Distinguished Endowed Chair in Pharmaceutical Technology & Professor of Pharmaceutics, University of Connecticut

Peter Park, Ph.D., Vice President, Biology,
 Mersana Therapeutics

Paul Parren, Ph.D., Senior Vice President and Scientific Director, Genmab  

Diane Paskiet, Ph.D., Director, Scientific Affairs,
 West Pharmaceutical Sciences

Ira H. Pastan, M.D., Head, Molecular Biology,
 NCI, NIH 

Jian Payandeh, Ph.D., Scientist, Structural Biology, Genentech, Inc.

Mark D. Pegram, M.D., Professor of Medicine,
 Stanford University Medical Center 

Knut Pettersson, Ph.D., Vice President, Preclinical Development, Athera Biotechnologies AB

Michael Pikal, Ph.D., Pfizer Distinguished Endowed Chair in Pharmaceutical Technology & Professor of Pharmaceutics,
 University of Connecticut 

Steven Potts, Ph.D., CEO, Histopathology Services, Flagship Biosciences

Mayo Pujols, MSc., Executive Director, Vaccines & Biologics Technical Operations,
 Merck & Co., Inc. 

Godfrey Rainey, Ph.D., Scientist II, ADPE/Research, MedImmune, LLC

Karthik Rajagopal, Ph.D., Scientist, Drug Delivery,
 Genentech, Inc.

Arvind Rajpal, Ph.D., Vice President, Protein Engineering,
 Rinat Pfizer

Henrik Rajesh Kumar Parshad, Principal Scientist,
 Novo Nordisk A/S

Vladimir Razinkov, Ph.D., Principal Scientist,
 Amgen

Pranhitha Reddy, Director, Cell Sciences, BioProcess and Analytical Sciences,
 Seattle Genetics

Jörg T. Regula, Ph.D., Head, Protein Analytics, Pharma Research and Early Development (pRED),
 Roche Diagnostics

Christopher L. Reyes, Vice President, Research and Development Biologics,
 Bionomics

Graham Reynolds, Vice President, Marketing and Innovation,
 West Pharmaceutical Services

Gertrudis Rojas, Ph.D., Group Leader (Protein Engineering), Systems Biology,
 Center of Molecular Immunology

Viktor Roschke, Ph.D., Vice President, Biopharmaceutical Research,
 Zyngenia, Inc.

Claudia Roth, Ph.D., President, Vetter Development Services USA, Inc.

Michael A. Ruberto, Ph.D., President,
 Material Needs Consulting, LLC 

Shannon Ryan, Ph.D., Process Development Scientist, EMD Millipore Corporation

Vikram Sadineni, Ph.D., Senior Research Investigator, Drug Product Science and Technology,
 Bristol-Myers Squibb Co.

Hardeep Samra, Ph.D., Scientist II, Formulation Sciences Department,
 MedImmune, Inc.

Aaron K. Sato, Ph.D, Vice President, Research,
 Sutro Biopharma

Melody Sauerborn, Ph.D., Senior Expert Immunogenicity, Bioanalysis,
 TNO Triskelion 

Patrick Sheehy, Ph.D., Associate Director, Pharmaceutical Development, Janssen Biologics Ireland 

Mark Shon, MBA, Vice President, Technology Development, Technology Marketing, SP Scientific

Christian Schöneich, Ph.D., Professor and Chair, Pharmaceutical Chemistry, University of Kansas
 

Volker Schellenberger, Ph.D., CEO and President, Amunix

Stefan Schmidt, Ph.D., Vice President, DSP,
 Rentschler Biotechnology

Nathan Scott, Ph.D., Principal Scientist - Biotherapeutic Discovery & Engineering,
 Pfizer

Martin Schwill, Ph.D., Scientist, Biochemistry,
 University of Zurich

Evgenyi Shalaev, Ph.D., FAAPS, Research Investigator,
 Allergan, Inc.

Elizabeth A. Specht, Ph.D., Scientist, Biological Sciences,
 University of California, San Diego

Eric V. Shusta, Ph.D., Professor, Chemical and Biological Engineering,
 University of Wisconsin-Madison

Vaughn Smider, M.D., Ph.D., Assistant Professor, Molecular Biology,
 The Scripps Research Institute

Edward J. Smith, Ph.D., Principal,
 Packaging Science Resources, LLC

Daniel Some, Ph.D., Principal Scientist,
 Wyatt Technology Corp.

Christoph Spiess, Ph.D., Scientist, Antibody Engineering,
 Genentech, Inc.

Julia Spitz, Ph.D., Associate Director, Protein Science,
 Boehringer Ingelheim Pharma GmbH & Co. KG 

Andrew Stephen, Ph.D., Acting Director, Protein Chemistry Laboratory, Frederick National Laboratory for Cancer Research, SAIC-Frederick, Inc.

Ivona Strug, Ph.D., Senior Biochemical Scientist,
 EMD Millipore 

Barbara Swanson, Ph.D., Director, Research, Sorrento Therapeutics, Inc. 

Bernie Sweeney, Ph.D., Senior Group Leader, Mammalian Expression, UCB 

Michael Taussig, Ph.D., Head, Technology Research Group, Babraham Bioscience Technologies

Lioudmila Tchistiakova, Ph.D., Senior Director, Global Biotherapeutic Technologies,
 Pfizer BioTx

T.N. Thompson, President,
 Millrock Technology, Inc.

Tracy Thompson, CEO,
 Polybatics

Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Head, Department of Industrial and Physical Pharmacy,
 Purdue University

Jens Traenkle, Ph.D., Head, PAT Biotechnology,
 Bayer Technology Services

Edward H. Trappler, Founder and President, Lyophilization Technology, Inc.
 

Mihriban Tuna, Ph.D., Vice President, Discovery, F-star

David Urech, Ph.D., CSO and Co-CEO,
 Numab AG

Gyorgy Vas, Ph.D., Research Fellow,
 Intertek Pharmaceutical Services

Jens H. Vogel, Ph.D., Executive Director & Head, Process Science USA,
 Boehringer-Ingelheim

David Volkin, Ph.D., Takeru and Aya Higuchi Distinguished Professor,
 The University of Kansas

Samadhi Vitharana, Ph.D., Senior Scientist, Core Sciences & Technology,
 Takeda

Christopher van der Walle, Ph.D., Principal Scientist, Development,
 MedImmune 

Annelise Vuidepot, Ph.D., Head, Protein Engineering & Biochemistry, Immunocore, Ltd.

Ping Wang, Ph.D., MBA, Senior Manager, Pharmaceutical & Material Sciences, DPD, PDMS,
 Janssen Research & Development

Abdul Wajid, Ph.D., Senior Director, Process and Manufacturing Sciences, XOMA
 

Thomas Weimer, Ph.D., Director, Recombinant Technology, CSL Behring GmbH 

Roland Weis, Ph.D., Head, Operations, VTU Technology GmbH 

Mark Welch, Ph.D., Director, Gene Design, DNA2.0, Inc.

Jim Wells, Ph.D., Professor, Pharmaceutical Chemistry and Cellular & Molecular Pharmacology,
 University of California, San Francisco

James W. West, Ph.D., Director of Research,
 CytomX Therapeutics, Inc.

Ann White, Ph.D., Senior Research Fellow,
 University of Southampton

Brian Wilbur, Ph.D., Process Development Engineer, Biotherapeutics Pharmaceutical Research & Development,
 Pfizer, Inc.

Michael V. Wiles, Ph.D., Senior Director, Technology Evaluation & Development,
 The Jackson Laboratory

K. Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Engineering and Biological Engineering,
 Massachusetts Institute of Technology

Ken Wong, Center for Extractables and Leachables, (CEL), ACDS – Specialty Analytical & Informatics (SAI),
 Merck & Co.

Anna M. Wu, Ph.D., Professor, Molecular and Medical Pharmacology, David Geffen School of Medicine; Founder and Chief Scientist,
 ImaginAb

Jiansheng Wu, Ph.D., Scientist, Protein Chemistry,
 Genentech, Inc.

Lihui Xu, Group Leader, Antibody Technology Team,
 Merrimack Pharmaceuticals

Yan-ping Yang, Ph.D., Director, Downstream Purification, Bioprocess Research & Development,
 Sanofi Pasteur

Hsih-Te Yang, Ph.D., Visiting Assistant Professor, Department of Systems Medicine, Keio University School of Medicine

Wan-Ching Yen, Ph.D., Senior Scientist II, Cancer Biology,
 OncoMed Pharmaceuticals, Inc.

Alexei Yeliseev, Ph.D., Staff Scientist, Protein Biochemistry, LMBB,
 NIH

SeongKyu Yoon, Ph.D., Assistant Professor & Director, Department of Chemical Engineering, Massachusetts Bio Manufacturing Center,
 University of Massachusetts 

Hagop Youssoufian, M.S.c., M.D., Executive Vice President, Research & Development, Progenics Pharmaceuticals, Inc.

Kevin Zen, Ph.D., Manager, Biologics Development, Allergan
 

Qinghai Zhang, Ph.D., Associate Professor, Integral Structural and Computational Biology, The Scripps Research Institute

Xiaotian Zhong, Ph.D., Principal Scientist & Lab Head, GBT,
 Pfizer Global BioTherapeutic R&D

Heng Zhu, Ph.D., Associate Professor, Pharmacology and Molecular Sciences, High Throughput Biology Center (HIT Center),
 Johns Hopkins University School of Medicine

Eugene Zhukovsky, Ph.D., CSO, Research,
 Affimed Therapeutics AG

John Zowtiak, Director, Device Development & Engineering,
 Johnson & Johnson

Andrew L. Zydney, Ph.D., Department Head and Walter L. Robb Family Chair, Chemical Engineering, The Pennsylvania State University
 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


PTK Event APP 
New this year!
The PepTalk App will allow attendees to browse the agenda, create custom schedules, navigate the exhibit hall and explore poster presentations.

2014 Brochure Cover 

Right Arrow Download the Brochure 

Right Arrow Event at-a Glance 

      Premier Sponsors: 

EMD Millipore 

 Novozymes (white) 

PerkinElmer NEW 2009 

 Protein Simple  

  

Right Arrow View All Sponsors 

Right Arrow View Media Partners 

Add to Outlook Add to Outlook 

Training Seminars 

Mon-Tues, January 13-14 

Biologics Formulation and Delivery  

 


Buzz Sessions
BuzZ Sessions are facilitated, small-group discussions. Interactive participation leads to problem-solving solutions and future collaborations around focused topics.
Click here for BuzZ topics